Faridoxorubicin
Faridoxorubicin (AVA-6000) is a prodrug that targets fibroblast activation protein alpha (FAPα) . It releases active doxorubicin through FAPα-mediated cleavage, enhancing drug exposure within tumors while reducing cardiac toxicity. Faridoxorubicin holds potential for research in solid tumors, such as liver metastases from colorectal cancer.
Product Specifications
CAS Number
1841402-73-0
Smiles
OC=1C2=C ([C@@H] (O[C@H]3C[C@H] (NC (=O) [C@H]4N (C ([C@H] (NC (=O) C=5C=CN=CC5) C) =O) CCC4) [C@H] (O) [C@H] (C) O3) C[C@@] (C (CO) =O) (O) C2) C (O) =C6C1C (=O) C=7C (C6=O) =C (OC) C=CC7
Molecular Formula
C41H44N4O14
Molecular Weight
816.81
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TRV-0032827-01 20 µL
Monoclonal Antibody to Nerve Growth Factor (NGF)
Sign In for Pricing
View Details TRV-0032827-02 100 µL
Monoclonal Antibody to Nerve Growth Factor (NGF)
Sign In for Pricing
View Details TRV-0032827-03 200 µL
Monoclonal Antibody to Nerve Growth Factor (NGF)
Sign In for Pricing
View Details TRV-0032827-04 1 mL
Monoclonal Antibody to Nerve Growth Factor (NGF)
Sign In for Pricing
View Details